• Aucun résultat trouvé

YON SUNG Fine C he

N/A
N/A
Protected

Academic year: 2022

Partager "YON SUNG Fine C he"

Copied!
1
0
0

Texte intégral

(1)

YON SUNG

YONSUNG

Fine Chemicals

FINE CHEMICALS CO., LTD.

The French National Agency for Medicines and Health Products Safety

143-147 bd Anatole France FR-93285 Saint Denis Cedex France

LETTER OF ACCESS

207, Sujeong-ro, Jangan-myeon, Hwaseong-si, Gyeonggi-do, 18581, Republic of Korea TEL: 82-31-351-6622 FAX: 82-31-351-6624

Apr. 27, 2017

Version Number of Active Substance Master File: Applicant's Part V6.0 & Restricted Part V5.0 Name of Active Substance: Latanoprost

Manufacturing site: Yonsung Fine Chemicals Co., Ltd.

207, Sujeong-ro, Jangan-Myeon, Hwaseong-Si, Gyeonggi-Do, 18581, Republic of Korea

Active Substance Master File Holder: Yonsung Fine Chemicals Co., Ltd.,

207, Sujeong-ro, Jangan-myeon, Hwaseong-si, Gyeonggi-do, 18581, Republic of Korea

The aforementioned Active Substance Master File holder hereby authorizes the French National Agency for Medicines and Health Products Safety/France to refer to and review the above mentioned Active Substance Master File in support of the following Marketing Authorization Application submitted by Laboratoire CHAUVIN:

Name of product: Vizilatan 0,05 mg/ml, collyre en solution Number ofDCP: DK/H/2754/001/DC

Name of Applicant or Marketing Authorization holder: Laboratoire CHAUVIN

416 rue Samuel Morse CS 99535 MONTPELLIER Cedex 2, 34961 France

The aforementioned Active Substance Master File holder commits to ensure batch to batch consistency and to inform the French National Agency for Medicines and Health Products Safety/France and Laboratoire CHA UVJN of any change in the Active Substance Master File.

The aforementioned Active Substance Master File bolder hereby is informed of and accepts that the EEA National Competent Authorities, the EMA including all CHMP and CVMP Members and their experts, and the Certification of Substances Division of the European Directorate for the Quality of Medicines &

Healthcare may share the Assessment Reports of the above mentioned Active Substance Master File amongst themselves.

Sincerely,

Director of Quality Department Yonsung Fine Chemicals Co., LTD

1/ 1

Références

Documents relatifs

To cite this article: Katrina Perehudoff (2020) Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines

La Société française de santé et environnement, en évoluant vers une Société francophone de santé et environnement (SFSE), peut jouer là un rôle croissant dans le domaine qui

Simon Brascoupé National Aboriginal Health Organization Doctor David Brown Canadian Imperial Bank of

The af orementioned Active Substance Master File holder hereby authorizes the ANSM, to refer to and review the above mentioned Active Substance Master File in

The aforementioned Active Substance Master File holder hereby authorises the Agence Nationale de Securite du Medicament et des Produits de Sante to refer to and

The aforementioned Active Substance Master File holder hereby authorizes the Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS), to refer to and review the

We also commit to inform about any major changes made in the specifications or methods

This WHO Quality Assurance Policy for the Procurement of Essential Medicines and other Health Products (the Policy) sets out the principles and requirements regulating WHO